Diagnosis: Tricuspid Regurgitation. Next Steps

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Technology

Background:

• Valvular heart disease is prevalent and managed by primary care providers (PCPs).
• Transcatheter interventions have advanced, reducing procedural risks for valve repair and replacement.
• Historically, high-risk patients, particularly those with isolated chronic tricuspid regurgitation, had limited treatment options.

Purpose of the Study:

• To highlight the evolving landscape of transcatheter interventions for valvular heart disease.
• To emphasize the benefits of these lower-risk procedures, especially for tricuspid regurgitation.
• To inform PCPs about optimal patient selection and referral for tricuspid valve intervention.

Main Methods:

• Review of current transcatheter techniques for valvular heart disease treatment.
• Analysis of patient outcomes with transcatheter tricuspid valve interventions.
• Assessment of the impact of these interventions on referral patterns and patient management.

Main Results:

• Transcatheter interventions have significantly lowered the risks associated with valve repair and replacement.
• Multiple transcatheter options now exist for tricuspid regurgitation, benefiting patients with right ventricular failure.
• Evidence suggests clear patient benefit from these emerging procedures, though many are still under study.

Conclusions:

• Transcatheter valvular interventions are transforming treatment paradigms, making procedures safer than watchful waiting for select patients.
• Patients with chronic tricuspid regurgitation and right ventricular failure may benefit from timely transcatheter intervention.
• PCP awareness is crucial for identifying and referring appropriate patients for tricuspid valve intervention, improving outcomes.